Evidence map›Paper›PMID 30705774›Full record

ReviewAging and disease2019

Rosenroot (

Wei Zhuang, Lifeng Yue, Xiaofang Dang, Fei Chen, Yuewen Gong, Xiaolan Lin, Yumin Luo

Abstract readReview
In one paragraph

Review in Aging and disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Salidroside in heavy metal toxicity: a mechanistic review of antioxidant, anti-inflammatory, and anti-apoptotic pathways.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wei Zhuang1Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing 100053, China.
Lifeng Yue2Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
Xiaofang Dang3Department of Pharmacy, Hospital of T.C.M.S Shijingshan District, Beijing 100043, China.
Fei Chen1Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing 100053, China.
Yuewen Gong4College of Pharmacy, University of Manitoba, Winnipeg R3E 0T5, Manitoba, Canada.
Xiaolan Lin1Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing 100053, China.
Yumin Luo5Institute of Cerebrovascular Disease Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing 100053, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is a progressive accumulation of changes in the body, which increases the susceptibility to diseases such as Alzheimer's disease, Parkinson's disease, cerebrovascular disease, diabetes, and cardiovascular disease. Recently, Chinese medicinal herbs have been investigated for their therapeutic efficacy in the treatment of some aging-related diseases.

Indexed as

cardioprotectionneurodegenerative diseasesRhodiola roseasalidroside

Identifiers

PMID30705774
PMCPMC6345333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.